Your donation goes to Imagine for Margo.
Payments are 100% secure.
Alexandre Javier's fundraising page
by Alexandre Javier for Imagine for Margo
I'm thrilled to share that I'll be running the Berlin Marathon in September 2025 to support a cause close to my heart: Imagine for Margo - Children without Cancer. This incredible charity has been leading the fight against childhood cancer since 2011, raising funds and advocating for research to better understand and cure these devastating diseases.
To make this effort as impactful as possible, I'm asking for your help. Whether through a donation or by spreading the word, every contribution makes a difference. There are no small gestures when it comes to supporting this vital work.
Donating is simple, 100% secure, and processed through Alvarum. Together, we can help Imagine for Margo continue to bring hope to children and families affected by cancer.
Thank you for your support and for being part of this journey with me!
To make this effort as impactful as possible, I'm asking for your help. Whether through a donation or by spreading the word, every contribution makes a difference. There are no small gestures when it comes to supporting this vital work.
Donating is simple, 100% secure, and processed through Alvarum. Together, we can help Imagine for Margo continue to bring hope to children and families affected by cancer.
Thank you for your support and for being part of this journey with me!
Target
61%
So far, I've raised
€ 610
With help of people.
On my target of € 1,000
On my target of € 1,000
I participate to the campaign
BMW Berlin Marathon 2025
BMW Berlin Marathon 2025
Imagine for Margo
L'association Imagine for Margo - reconnue d'intérêt général - mobilise les acteurs clés de la santé et collecte des dons afin d'accélérer la recherche européenne contre le cancer des enfants. L'association mène également des actions pour sensibiliser à la cause, améliorer le bien-être des enfants malades et soutenir leurs familles. Depuis sa création en 2011, Imagine for Margo est devenue un acteur majeur de l’oncologie pédiatrique à l’échelle nationale et un acteur influent en Europe.
